Ethereum Price Today, Nov. 6, 2025: ETH steadies near $3.4K as spot ETF outflows stretch to a 6th day; Justin Sun stakes 45K ETH; ‘Fusaka’ upgrade eyed for Dec. 3

Ethereum Price Today, Nov. 6, 2025: ETH steadies near $3.4K as spot ETF outflows stretch to a 6th day; Justin Sun stakes 45K ETH; ‘Fusaka’ upgrade eyed for Dec. 3

Updated: Nov. 6, 2025 (UTC)


At a glance

  • Price: ETH is trading around $3,380–$3,480 today after dipping to an intraday low near $3,277 before rebounding. Market cap sits around $409B. [1]
  • ETF flows: U.S. spot Ethereum ETFs logged a sixth straight day of net outflows through Nov. 5, with -$118.5M yesterday; BlackRock’s ETHA saw -$146.6M while Fidelity’s FETH took in +$3.5M. [2]
  • On‑chain:Justin Sun moved 45,000 ETH (~$154.5M) from Aave to Lido for staking, per Arkham-linked trackers and crypto trade press. [3]
  • Network fees: Ethereum gas fell under 1 gwei this morning, keeping typical on‑chain actions under $1. [4]
  • Roadmap: Core devs are targeting ~Dec. 3 for the next network upgrade, “Fusaka,” which introduces PeerDAS to boost rollup capacity. [5]

Market snapshot: Volatility cooled after a sharp mid‑week reset

After a choppy first half of the week, ether is little changed on the day and holding near the mid‑$3Ks. Intra‑day, ETH traded between roughly $3,277–$3,478 and is hovering around $3.39K at press time. The latest Ethereum market cap reading is about $409B. The bounce follows Tuesday/Wednesday’s broad crypto shakeout that saw more than $1.6B in leveraged positions liquidated across majors, according to CoinDesk’s market desk. [6]

Flows watch: Six straight outflow days for U.S. spot ETH ETFs

Fresh data from Farside Investors show net outflows for U.S. spot Ethereum ETFs on Oct. 29, 30, 31 and Nov. 3–5, marking a six‑session streak through Wednesday. Nov. 5 stood at -$118.5M total, with BlackRock’s ETHA -$146.6M partly offset by Fidelity’s FETH +$3.5M. Persistent redemptions help explain why ETH has struggled to reclaim the upper end of its range despite today’s intraday recovery. (Note: ETF flow figures are reported after the U.S. trading day; today’s final tally will post later.) [7]

Whale & staking flows: Justin Sun rotates 45K ETH into Lido

On‑chain watchers flagged Justin Sun moving 45,000 ETH (≈$154.5M) from Aave to Lido staking. While a single address doesn’t set the market, it tilts near‑term supply off exchanges and spotlights liquid staking yields that have hovered in the ~2.5–3% 30‑day APY range for stETH this fall. [8]

Network fees: Sub‑$1 transactions return

Gas prices fell below 1 gwei this morning (UTC), keeping common actions—simple transfers, DEX swaps, bridging—well under $1 for most users. While cheap blockspace is a usability win, it slows the EIP‑1559 burn, which can dampen ETH’s deflationary impulse when activity is light. [9]

Roadmap & catalysts: ‘Fusaka’ targeted for Dec. 3; PeerDAS to scale rollups

Core developers are aiming for ~Dec. 3 to activate “Fusaka” on mainnet (timing still tentative). A headline feature is PeerDAS, a data‑availability upgrade designed to let Layer‑2 rollups post more data at lower cost—translating into higher throughput and cheaper L2 transactions over time. Expect more precise timing on forthcoming dev calls and client releases. [10]

Derivatives & the week ahead

Beyond spot flows, structure matters: Cboe plans to debut “continuous” (long‑dated perpetual‑style) futures for Bitcoin and Ether on Nov. 10, pending approvals—potentially adding new hedging and speculative channels for ETH exposure next week. Keep an eye on basis and funding as those products go live. [11]

Bigger picture: What pros are watching

  • Institutional positioning: Wall Street targets remain wide—from $4,300 (Citi) to $7,500 (Standard Chartered) for year‑end—underscoring how macro, ETF flows and roadmap execution can swing sentiment. [12]
  • ETF tape at 4 p.m. ET: After five–six sessions of redemptions, another negative print would confirm persistent profit‑taking; a flip to inflows would be a near‑term tailwind. [13]
  • L2 metrics post‑Fusaka: If PeerDAS does what it says on the tin, watch rollup fees/throughput as an adoption driver into year‑end. [14]

Key numbers today (UTC)

  • Spot range: ~$3,277 (low) to ~$3,478 (high)
  • Market cap: ~$409B
  • Gas (Etherscan snapshot):Low/Avg/High ≈ 0.64/0.65/0.89 gwei this morning
  • Latest verified ETF flows (Nov. 5):-$118.5M total; ETHA -$146.6M, FETH +$3.5M
    Figures from the sources cited above. [15]

FAQ

Why does cheap gas matter for ETH’s investment case?
Low gas is great for users, but it reduces fee burn under EIP‑1559. When network activity spikes again (especially on L2s), burn can outpace issuance and re‑tighten ETH supply—a key part of the “ultrasound money” thesis. [16]

What is PeerDAS in the ‘Fusaka’ upgrade?
Peer Data Availability Sampling lets nodes verify large blobs of rollup data without downloading everything, boosting data throughput and L2 scalability. In practice, that should mean cheaper, faster rollups if adoption is strong. [17]

Are ETFs the main driver for ETH now?
They’re one major channel for institutional capital. Persistent outflows can weigh on price; sustained inflows often coincide with stronger trends—one reason daily flow dashboards like Farside’s are closely watched. [18]


Methodology & sources

Prices and intraday ranges are taken from live market feeds (see the interactive chart above). ETF flow figures are from Farside Investors’ U.S. Ethereum ETF dashboard. On‑chain flow items (Justin Sun) reference trade‑press coverage of Arkham Intelligence alerts. Upgrade timing and details draw on reporting from The Block, Decrypt and CoinDesk. Macro/market context includes CoinDesk’s liquidation recap and Reuters’ sell‑side forecasts. [19]

Disclosure: This article is for information only and is not investment advice. Crypto assets are volatile and can lose value rapidly. Do your own research.

If you invest in Ethereum.. HOLD ON!! ETH to skyrocket 🚀📈

References

1. etherscan.io, 2. farside.co.uk, 3. www.odaily.news, 4. etherscan.io, 5. www.theblock.co, 6. www.coindesk.com, 7. farside.co.uk, 8. www.odaily.news, 9. etherscan.io, 10. www.theblock.co, 11. www.bloomberg.com, 12. www.reuters.com, 13. farside.co.uk, 14. decrypt.co, 15. etherscan.io, 16. www.okx.com, 17. decrypt.co, 18. farside.co.uk, 19. farside.co.uk

Stock Market Today

  • Snap Stock Surges 18% on $400 Million Perplexity AI Deal
    November 6, 2025, 7:33 AM EST. Snap (SNAP) jumped 18% in pre-market after beating Q3 revenue estimates and announcing a $500 million stock buyback. Revenue rose to $1.51 billion, above expectations of $1.49B, while daily active users reached 477 million. The company inked a $400 million partnership with AI search startup Perplexity to embed its conversational search into Snapchat, starting in early 2026. The move diversifies revenue beyond ads, though the company warns about potential Q4 headwinds from Apple/Google age-verification changes and Australia's restrictions. Profitability improved, with net losses narrowing over 30% YoY and adjusted EBITDA of $182 million. Analysts' price targets and upside discussions remain mixed amid a year-to-date decline.
  • Is Elevance Health a Hidden Opportunity After a 24.5% Drop in 2025?
    November 6, 2025, 7:28 AM EST. Elevance Health has tumbled in 2025 amid policy shifts and broader healthcare-sector volatility, with a year-to-date drawdown and a longer 24.5% slide that has investors rethinking value. The piece weighs near- and long-term catalysts, noting that a high valuation score isn't translating into certainty as government program changes loom for managed care. The core takeaway is a rigorous DCF assessment, which, using current free cash flow of $3.6B and projected growth, yields an intrinsic value around $1,090.84 per share-roughly 71% above current prices, signaling undervaluation. Still, equity investors should monitor the PE ratio, competitive dynamics, and policy risk, which could affect how quickly this perceived bargain translates into realized gains.
  • Inflammation Biotech Evommune Starts NYSE Trading in $150M IPO
    November 6, 2025, 7:24 AM EST. Evommune is heading to the NYSE with a $150 million IPO to fund two clinical-stage assets. The Palo Alto biopharma is offering 9.3 million shares at $16 each, pricing in the $15-$17 range. Gross proceeds are $150 million, potentially rising by about $22.5 million if underwriters exercise their option for an additional 1.4 million shares. Trading under the ticker EVMN could begin today. The company plans to use the funds to advance two phase 2 programs, including EVO756, an oral MRGPRX2 antagonist being studied for CSU and atopic dermatitis (AD). Topline data for CSU from a phase 2 study showed 93% responses at four weeks. Data for AD topline in H2 2026. Evommune priced amid a broader biotech IPO backdrop as MapLight Therapeutics went public last week.
  • Arm Holdings Stock Surges on Q2 Beat, Strong AI Demand Lifts Outlook
    November 6, 2025, 7:22 AM EST. Arm Holdings (ARM) stock jumps about 5-6% in pre-market trading after reporting a Q2 beat that topped revenue and earnings estimates and issuing stronger Q3 guidance. The company posted revenue of $1.14 billion, up 34% year over year, and EPS of $0.22, exceeds consensus of $0.13. Arm also raised its quarterly revenue guide to about $1.23 billion versus the $1.10 billion expected. Royalty revenue reached a record $620 million, up 21%, led by data centers, automotive, and IoT, with hyperscalers like Google, Amazon, and Microsoft boosting Arm-based deployments. Licensing revenue rose 56% to $515 million. The AI infrastructure buildout underscores demand for Arm's energy-efficient designs, and management hints at potential in-house chip development beyond licensing.
  • Capital One Stock Prediction: Analysts See Up to 29% Upside by 2027 on Discover Acquisition
    November 6, 2025, 7:20 AM EST. Capital One (NYSE: COF) trades around $221 with an average target near $260, implying ~18% upside. Targets span $290 (high) and $210 (low), with a median near $258 and a mix of 14 Buys, 3 Outperforms, and 6 Holds. Growth projections call for revenue up about 19% annually through 2027, supported by operating margins near 48% and a forward multiple around 9.7x. A guided model points to ~$285/share by 2027, or about 29% total upside (12% annualized). The story centers on the Discover acquisition, expanded payments network, and stable credit trends amid solid consumer spending, though conviction remains modest and upside depends on continued earnings growth and credit stability.
Interstellar Comet 3I/ATLAS: A Visitor from Beyond the Solar System
Previous Story

Comet 3I/ATLAS today (6 Nov 2025): China’s Mars orbiter snaps new photos as the interstellar visitor turns bluer and shows puzzling acceleration

Gold Bonanza 2025: Price Soars Past $4,400 as Diamond District Frenzy Hits New York – Is $5,000 Next?
Next Story

Gold Price Today, Nov 6, 2025: Spot Reclaims $4,000 as Dollar Softens—Traders Eye Fed Path, Shutdown & Tariff Ruling

Go toTop